Holding(s) in Company

Dechra Pharmaceuticals PLC 08 September 2005 Dechra Pharmaceuticals PLC ('the Company') Holding(s) in Company The Company was notified by Barclays PLC that through the legal entities of Barclays Global Investors Ltd, Barclays Capital Securities Ltd, Barclays Life Assurance Co Ltd and Gerrard Ltd, Barclays PLC has a notifiable interest in 2,038,336 ordinary shares of 1p each in the Company ('Ordinary Shares'), representing approximately 3.99 per cent. of the Company's issued ordinary share capital. These Ordinary Shares are registered as follows: Registered Holder Ordinary Shares Barclays Capital Nominees Limited 571,658 Chase Nominees Ltd a/c 16376 28,830 Chase Nominees Ltd a/c 21359 114,544 Chase Nominees Ltd a/c 28270 35,282 Chase Nominees Ltd a/c 28270 22,282 JP Morgan (BGI Custody) a/c 16341 56,561 JP Morgan (BGI Custody) a/c 16341 15,934 JP Morgan (BGI Custody) a/c 16344 21,055 JP Morgan (BGI Custody) a/c 16345 34,675 JP Morgan (BGI Custody) a/c 16400 371,257 JP Morgan (BGI Custody) a/c 16480 485,391 JP Morgan (BGI Custody) a/c 16482 250,007 JP Morgan (BGI Custody) a/c 18409 29,412 R C Greig Nominees Limited a/c 1,448 Total 2,038,336 08 September 2005 This information is provided by RNS The company news service from the London Stock Exchange GGLNRVGKZM
UK 100

Latest directors dealings